Related Experiment Video

Updated: May 17, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

The natural history of compensated HCV-related cirrhosis: a prospective long-term study

Eduardo Vilar Gomez1, Yoan Sanchez Rodriguez, Luis Calzadilla Bertot

  • 1Department of Researches, National Institute of Gastroenterology, Havana, Cuba. vilar@infomed.sld.cu

Journal of Hepatology
|November 1, 2012
PubMed

Insights

Compensated cirrhosis from Hepatitis C virus (HCV) in Latin America shows high risks. Patients with esophageal varices face significantly greater mortality, liver transplantation, and complication rates over six years.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Viral Hepatitis Research

Background:

  • The natural history of Hepatitis C virus (HCV)-related compensated cirrhosis is understudied in Latin America.
  • Limited data exists on long-term outcomes for this patient population.

Purpose of the Study:

  • To evaluate mortality and clinical outcomes in patients with compensated HCV-related cirrhosis.
  • To assess the impact of esophageal varices on patient prognosis over a 6-year follow-up period.

Main Methods:

  • Prospective recruitment of 402 patients with compensated HCV-related cirrhosis.
  • Stratification into stage 1 (no varices) and stage 2 (presence of varices) based on D'Amico criteria.
  • Follow-up for overall mortality, liver transplantation, and clinical complication rates.

Main Results:

  • Over 6 years, cumulative mortality or liver transplantation was 15% for stage 1 and 45% for stage 2 (p<0.001).
  • Hepatocellular carcinoma (HCC) incidence was 9% in patients without varices versus 29% with varices (p<0.001).
  • Clinical liver-related complications occurred in 26% of stage 1 patients compared to 66% of stage 2 patients (p<0.001).

Conclusions:

  • Compensated cirrhotic patients with esophageal varices (stage 2) experience significantly higher morbidity and mortality.
  • Early identification and management of varices are crucial for improving outcomes in HCV-related cirrhosis.
Abstract

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...